Investors Capital Advisory Services’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-12,687
Closed -$148K 720
2016
Q1
$148K Sell
12,687
-6,110
-33% -$85K 0.03% 599
2015
Q4
$374K Sell
18,797
-1,338
-7% -$33.1K 0.07% 375
2015
Q3
$487K Buy
20,135
+3,583
+22% +$93.1K 0.1% 290
2015
Q2
$420K Buy
16,552
+2,294
+16% +$60.8K 0.08% 369
2015
Q1
$341K Buy
14,258
+300
+2% +$7.59K 0.06% 420
2014
Q4
$312K Buy
13,958
+2,158
+18% +$56.2K 0.06% 432
2014
Q3
$323K Sell
11,800
-9,776
-45% -$295K 0.06% 412
2014
Q2
$685K Buy
21,576
+13,243
+159% +$394K 0.11% 273
2014
Q1
$214K Buy
+8,333
New +$227K 0.05% 512

Other funds holding CLMT

Investors Capital Advisory Services's CLMT Position: Q2 2016 in Review

Investors Capital Advisory Services sold out of Calumet Specialty Products (CLMT) in Q2 2016, closing a stake of 12,687 shares — an estimated $148K sold.

Investors Capital Advisory Services first reported a position in CLMT in Q1 2014 and held it in 9 quarters. The position peaked at $685K in Q2 2014. 90 funds tracked by Wall St. Rank hold CLMT as of Q2 2016.

  • Investors Capital Advisory Services reported no remaining Calumet Specialty Products position as of Q2 2016 after selling out during the quarter.
  • Investors Capital Advisory Services sold 12,687 Calumet Specialty Products shares in Q2 2016, an estimated $148K.
  • Investors Capital Advisory Services first reported a position in Calumet Specialty Products in Q1 2014 and held it in 9 quarters.
  • Investors Capital Advisory Services's Calumet Specialty Products position peaked at $685K in Q2 2014.
  • 90 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.